Suppr超能文献

前庭性偏头痛中位置性垂直性眼震的临床标准

Clinical criteria of positional vertical nystagmus in vestibular migraine.

作者信息

El-Badry Mohamed Mohamed, Samy Hesham, Kabel Abdel Mageed, Rafat Fatma Mohamed, Sanyelbhaa Hossam

机构信息

a Faculty of Medicine, Audio-Vestibular Unit , Minia University , Almenia , Egypt.

b Faculty of Medicine, Department of Otolaryngology , Menoufia University , Shebien Elkoom , Egypt.

出版信息

Acta Otolaryngol. 2017 Jul;137(7):720-722. doi: 10.1080/00016489.2017.1318220. Epub 2017 Apr 27.

Abstract

OBJECTIVES

The goal of this study was to identify key diagnostic criteria for positional vertical nystagmus caused by vestibular migraine (VM).

MATERIALS AND METHODS

The study group included a case series of 13 subjects with VM (10 females and three males with age 38.6 ± 8.9 years); they were complaining of positional vertigo. They were subjected to thorough audiovestibular examination and treated with cinnarizine or topiramate Results: The entire study group demonstrated positional vertical nystagmus (eight patients had up-beating nystagmus and five patients had down-beating nystagmus). The vertigo and nystagmus were elicited in one or more of the following positions: the right & left Dix-Hallpike, supine with head center, head right, and head left positions. The nystagmus had no latency period. It was persistent, non-fatigable and markedly reduced by visual fixation. Prophylactic therapy of VM (topiramate or cinnarizine) cured the positional vertigo in 92% of the study group. Neither the positional vertigo nor the nystagmus recurred in a 3-6 months follow-up period.

CONCLUSIONS

VM can induce characteristic form of vertical positional nystagmus and vertigo, which would be treated by medications used for controlling the VM.

摘要

目的

本研究的目的是确定前庭性偏头痛(VM)引起的位置性垂直性眼球震颤的关键诊断标准。

材料与方法

研究组包括13例VM患者的病例系列(10名女性和3名男性,年龄38.6±8.9岁);他们主诉有位置性眩晕。对他们进行了全面的听前庭检查,并用桂利嗪或托吡酯进行治疗。结果:整个研究组均表现出位置性垂直性眼球震颤(8例患者为上跳性眼球震颤,5例患者为下跳性眼球震颤)。眩晕和眼球震颤在以下一个或多个位置诱发:左右Dix-Hallpike试验、头位居中仰卧位、头向右侧位和头向左侧位。眼球震颤无潜伏期。它持续存在,不易疲劳,视觉注视可使其明显减轻。VM的预防性治疗(托吡酯或桂利嗪)使92%的研究组患者的位置性眩晕得到治愈。在3至6个月的随访期内,位置性眩晕和眼球震颤均未复发。

结论

VM可诱发特征性的垂直位置性眼球震颤和眩晕,可通过用于控制VM的药物进行治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验